Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunity
Santamorena M, Tischer-Zimmermann S, Bonifacius A, Mireisz C, Costa B, Khan F, Kulkarni U, Lauruschkat C, Sampaio K, Stripecke R, Blasczyk R, Maecker-Kolhoff B, Kraus S, Schlosser A, Cicin-Sain L, Kalinke U, Eiz-Vesper B